Drug use and dosing in chronic kidney disease

Annals of the Academy of Medicine Singapore

Volumn 38, Issue 12, 2009, Pages 1095-1103

  Hassan, Yahaya ^a   Al Ramahi, Rowa'J ^a   Abd Aziz, Noorizan ^a   Ghazali, Rozina ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b Penang Hospital   (Malaysia)

Author keywords

Dosage adjustment; Renal impairment; Stepwise approach

Indexed keywords

AMPHOTERICIN B; ANTACID AGENT; BARBITURIC ACID DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FERROUS SULFATE; FUROSEMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; KETOCONAZOLE; LITHIUM; MANNITOL; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PENICILLIN G; PHENYTOIN; PHOSPHATE BINDING AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE; RIFAMPICIN; SALICYLIC ACID DERIVATIVE; SULFONYLUREA DERIVATIVE; TACROLIMUS; TETRACYCLINE; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG USE; HUMAN; KIDNEY FUNCTION; MEDICATION ERROR; NEPHROTOXICITY; PHARMACIST; PHYSICIAN; PRESCRIPTION; REVIEW;

EID: 76149109128     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Macgregor MS, Boag DE, Innes A. Chronic kidney disease: evolving strategies for detection and management of impaired renal function. Q J Med 2006;99:365-75.
2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at: http://www.kidney.org/ professionals/KDOQI/guidelines-ckd/toc.htm. Accessed 4 March 2009.
3. Swan SK, Bennett WM. Drug dosing guidelines in patients with renal failure. West J Med 1992;156:633-8.
4. Kappel J, Calissi P. Safe drug prescribing for patients with renal insufficiency. CMAJ 2002;166:473-7.
5. Gabardi S, Abramson S. Drug dosing in chronic kidney disease. Med Clin North Am 2005;89:649-87.
6. Perazella MA, Parikh C. Pharmacology. Am J Kidney Dis 2005; 46:1129-39.
7. Nolin TD, Frye RF, Matzke GR. Hepatic drug metabolism and transport in patients with kidney disease. Am J Kidney Dis 2003;42:906-25.
8. Manley HJ, Cannella CA, Bailie GR, St Peter WL. Medication-related problems in ambulatory hemodialysis patients: A pooled analysis. Am J Kidney Dis 2005;46:669-80.
9. Manley HJ, Debra K Drayer DK, Richard S Muther RS. Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrology 2003;4:10.
10. Fijn R, Bemt VD, Chow M, De Blaey CT, De Jong-Van den Berg LT, Brouwers JR. Hospital prescribing errors: epidemiological assessment of predictors. Br J Clin Pharmacol 2002;53:326-31.
11. Fattinger K, Roos M, Verge'res P, Holenstein C, Kind B, Masche U, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 2000;49:158-67.
12. Bonk ME, Krown H, Matuszewski K, Oinonen M. Potentially inappropriate medications in hospitalized senior patients. Am J Health Syst Pharm 2006;63:1161-5.
13. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital - their severity and cost involved. Pharmacoepidemiol Drug Safe 2003;12:687-92.
14. Van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet P. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother 2006;40:1254-60.
15. Nightingale PG, Adu D, Richards NT, Peters M. Implementation of rules based computerized bedside prescribing and administration: intervention study. BMJ 2000;320:750-3.
16. Long CL, Raebel MA, Price DW, Magid DJ. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004;38:853-8.
17. Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function -an underestimated problem? Nephrol Dial Transplant 2006;21:3164-71.
18. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2003;57:513-21.
19. Bonapace CR, White RL, Friedrich LV, Bosso JA. Differences in antimicrobial drug exposures in patients with various degrees of renal function based on recommendations from dosing references. Pharmacotherapy 2002;22:1097-104.
20. Preston SL, Briceland LL, Lomaestro BM, Lesar TS, Bailie GR, Drusano GL. Dosing adjustment of 10 antimicrobials for patients with renal impairment. Ann Pharmacother 1995;29:1202-7.
21. Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 2003;15:331-5.
22. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003;33:10-3.
23. Yap C, Dunham D, Thompson J, Baker D. Medication dosing errors for patients with renal insufficiency in ambulatory care. Jt Comm J Qual Patient Saf 2005;31:514-21.
24. Salomon L, Levu S, Deray G, Launay-Vacher V, Brucker G, Ravaud P. Assessing residents' prescribing behavior in renal impairment. Int J Qual Health Care 2003;15:235- 40.
25. Chertow GM, Lee J, Kumperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001;286:2839-44.
26. Mangino PD. Role of the pharmacist in reducing medication errors. J Surg Oncol 2004;88:189-94.
27. Galanter WL, Didomenico RJ, Polikaitis A. A trial of automated decision support alerts for contraindicated medications using computerized physician Order entry. J Am Med Inform Assoc 2005;12:269-74.
28. Walton R, Dovey S, Harvey E, Freemantle N. Computer support for determining drug dose: systematic review and meta analysis. BMJ 1999;318:984-90.
29. Munroe WP, Kunz K, Israel CD, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997;19:113-23.
30. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999;47:695-700.
31. Kaboli PJ, Hoth AB, Mcclimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care. Arch Intern Med 2006;166:955-64.
32. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
33. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8.
34. Gandhi PJ, Smith BS, Tataronis GR, Mass B. Impact of a pharmacist on drug costs in a coronary care unit. Am J Health Syst Pharm 2001;58:497-503.
35. Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med 2001;16:369-75.
36. Joy MS, DeHart RM, Gilmartin C, Hacheg DM, Hudson JQ, Pruchnicki M, et al. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: A joint opinion by the nephrology and ambulatory care practice and research networks of the American college of clinical pharmacy. Am J Kidney Dis 2005;45:1105-18.
37. Kilian R, Kliniken L. Drugs, renal failure and the clinical pharmacist. Eur J Hosp Pharmacy 2004;2:18-23.
38. Hodgkinson B, Koch S, Nay R, Nichols K. Strategies to reduce medication errors with reference to older adults. Int J Evid Based Healthc 2006;4:2-41.
39. th ed. American College of Clinical Pharmacy, 2007.
40. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
41. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:155A.
42. Spruill WJ, Wade WE, Cobb HH. Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy. Am J Health Syst Pharm 2007;64:652-60.
43. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-83.
44. Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2006;2:80-91.
45. Guo X, Nzerue C. How to prevent, recognize, and treat drug-induced nephrotoxicity. Cleve Clin J Med 2002;69:289-312.
46. Taber S, Mueller B. Drug-associated renal dysfunction. Crit Care Clin 2006;22:357- 74.
47. th ed. McGraw-Hill Medical, 2005.
48. McEvoy GK, Miller J, Snow EK, Welsh OH, Litvak K, editors. American Hospital Formulary System (AHFS) Drug Information 2008. Bethesda: American Society of Health System Pharmacists, 2008.
49. Sweetman SC, editor. Martindale: The Complete Drug Reference. 35th ed. London: Pharmaceutical Press, 2007.
50. th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2008.
51. th ed. International. Cleveland: American Pharmaceutical Association, 2008.
52. th ed. Philadelphia: American College of Physicians, 2007. Available at: http://www.kdp-baptist.louisville.ed. Accessed 4 March 2009.
53. th ed. Thomson, 2008.